Open access publishing of pharma-sponsored research: insights from a Scientific Publications Lead
Slávka Baróniková shares her opinions on open access publishing and suggests how this can be successfully achieved within pharma.
cOAlition S bypass a block on the road to open access
cOAlition S Rights Retention Strategy aims to safeguard researchers’ intellectual ownership, enabling embargo-free sharing of research in online repositories.
Journal open access cost breakdowns will be needed for cOAlition S support
From 2022, journals will need to follow cOAlition S price transparency requirements to get paid. Find out more about the frameworks and potential benefits here.
cOAlition S publishes updated criteria for hybrid journals transitioning to open access
Following a public consultation, updated cOAlition S guidance relaxes the criteria for transformative journals, prompting commitments from further journals.
Are attitudes becoming more supportive of open science?
The latest State of Open Data survey results show changing trends in researchers’ attitudes towards the use of open data.
Draft guidance from cOAlition S supports transformative journals’ transition to full open access
Find out more about the requirements cOAlition S plans to set for ‘transformative journals’.
Plan S version 2: the right approach to full open access?
Following the revised guidance on Plan S, Bernd Pulverer questions whether cOAlition S is making the most of the opportunity to push for open science.
MPIP: Overcoming barriers to open access for industry
A new tool from MPIP provides easily accessible information on open access options for industry-funded research.
How researchers are changing the way they publish
There are a number of publishing features to consider when selecting a journal. Find out how researchers are navigating the options to their best advantage.
Authors undeterred by rising article processing charges
Article processing charges are increasing, but a recent study finds that higher charges seem to attract rather than deter authors from submitting to open access journals.
Open access and Plan S: what do key stakeholders think?
ISMPP’s first white paper, ‘A multistakeholder discussion on open access and medical publishing’ is now available.
Are ‘funding body journals’ the future of scientific publishing?
A recent article from The Chronicle of Higher Education discusses the potential benefits associated with journals that are established by funding bodies.
Public feedback to shape Plan S implementation guidance
Feedback on the implementation guidance for Plan S highlights key themes for consideration.
Should pharmaceutical companies be doing more to advocate open access?
Many public funders have mandated open access to their research and support Plan S. Should pharmaceutical companies follow suit?
China backs the Plan S open access initiative
China has pledged its support for Plan S, an initiative striving to make the results of publicly funded research freely available immediately on publication.